Concentrix saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, rising from 63 to 80.
Looking For The Best Stocks To Buy And Watch? Start Here
IBD's proprietary RS Rating identifies market leadership by showing how a stock's price movement over the last 52 weeks compares to that of other stocks on the major indexes.
History shows that the market's biggest winners tend to have an RS Rating of over 80 as they begin their biggest runs.
Concentrix is not currently near a potential buy zone. See if the stock goes on to build a base that could launch a new move.
While earnings growth fell in the company's most recent quarterly report from 3% to 0%, sales grew 2%, up from -1% in the previous report.
The company earns the No. 27 rank among its peers in the Computer Software-Enterprise industry group. Palantir Technologies, Cloudflare and Shopify are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
